Advertisement
Organisation › Details
Quotient (Group)
Quotient Sciences, a global pharmaceutical development, clinical pharmacology, and clinical and commercial manufacturing organization, delivers innovative, customized solutions for pharmaceutical and biotech customers through both individual and integrated services. Its Translational Pharmaceutics® platform integrates formulation development, real-time adaptive GMP manufacturing and clinical research for the continuous improvement of drug development programs, and is proven to accelerate timelines and reduce cost. *
Start | 2014-04-25 renamed | |
Industry | diagnostics (medical/biological) | |
Person | Egerton, Mark (Quotient Bioresearch 201010) | |
Street | Mere Way | |
City | NG11 6JS Ruddington, Nottingham | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | E: 501 to 1,000 (2017-11-10) |
* Document for »About Section«: | ||
Record changed: 2024-07-04 |
Advertisement
More documents for Quotient (Group)
- [1] eXmoor Pharma Concepts Ltd.. (11/16/23). "Press Release: eXmoor Appoints Matthew Paterson as First Chief Commercial Officer". Bristol....
- [2] Valneva S.E.. (7/29/21). "Press Release: Valneva Appoints Peter Buhler as Chief Financial Officer". Saint-Herblain....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top